|
|
|
Volumn 28, Issue 6 SUPPL. 1, 1996, Pages 30-33
|
|
The European experience with mycophenolate mofetil
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
CREATININE;
CYCLOSPORIN;
INOSINATE DEHYDROGENASE;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
THYMOCYTE ANTIBODY;
ADULT;
AGED;
B LYMPHOCYTE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
ENZYME INHIBITION;
EUROPE;
FEMALE;
GASTROINTESTINAL SYMPTOM;
GRAFT REJECTION;
HEMATOLOGIC DISEASE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY ALLOGRAFT;
KIDNEY FUNCTION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NUCLEOTIDE METABOLISM;
OPPORTUNISTIC INFECTION;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
T LYMPHOCYTE;
ADOLESCENT;
ADULT;
AGED;
DOUBLE-BLIND METHOD;
EUROPE;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MIDDLE AGED;
MYCOPHENOLIC ACID;
|
|
EID: 0029829009
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (16)
|
|
References (0)
|
